对直接因子XA抑制剂相关出血或紧急手术前进行血栓复合缩剂
Joseph R Shaw1, Abdulrahman Abdulaziz Almujalli1, Yan Xu1
1Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Thrombosis research
|October 3, 2024
概括
四因子前激素复合缩剂 (4F-PCC) 在三分之二的患者中有效控制了与Xa因子抑制剂 (FXaI) 相关的出血. 血栓塞栓事件很少发生,这表明4F-PCC是一种有前途的FXaI出血管理策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 与Xa因子抑制剂 (FXaI) 相关的出血事件很常见,并导致显著的发病率.
- 需要有效和负担得起的FXaI相关出血管理策略.
研究的目的:
- 在患有FXaI相关出血或需要紧急手术的患者中评估4因子前列红素复合度 (4F-PCC) 的静血疗效和安全性.
- 评估4F-PCC给药后发生的血栓塞栓事件的发生率.
主要方法:
- 一个单一中心的回顾性队列研究,针对因FXaI相关出血或紧急手术而接受4F-PCC治疗的患者.
- 收集了血液静止疗效和30天血栓栓塞风险的数据.
- 患者接受了25-50 IU/kg的4F-PCC.
主要成果:
- 在66.7%的患有FXaI相关出血的患者中,获得了有效的血静.
- 在接受紧急手术的患者中,95.5%的手术静血被评为正常.
- 血栓栓塞的30天风险为7.6%,整体死亡率为22.9%.
结论:
- 4F-PCC在三分之二的患有FXaI相关出血的患者中显示出血静效.
- 血栓栓塞栓事件并不常见,这表明4F-PCC是一种可行的治疗选择.
- 4F-PCC是管理FXaI相关出血的一个有希望的策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
Aneurysm IV: Nursing Management
621
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
621
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482


